GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (WBO:ABBV) » Definitions » Cyclically Adjusted PS Ratio

AbbVie (WBO:ABBV) Cyclically Adjusted PS Ratio : 6.09 (As of May. 15, 2024)


View and export this data going back to 2018. Start your Free Trial

What is AbbVie Cyclically Adjusted PS Ratio?

As of today (2024-05-15), AbbVie's current share price is €148.62. AbbVie's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €24.39. AbbVie's Cyclically Adjusted PS Ratio for today is 6.09.

The historical rank and industry rank for AbbVie's Cyclically Adjusted PS Ratio or its related term are showing as below:

WBO:ABBV' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.91   Med: 6.12   Max: 8.05
Current: 6.09

During the past years, AbbVie's highest Cyclically Adjusted PS Ratio was 8.05. The lowest was 4.91. And the median was 6.12.

WBO:ABBV's Cyclically Adjusted PS Ratio is ranked worse than
84.7% of 745 companies
in the Drug Manufacturers industry
Industry Median: 2.17 vs WBO:ABBV: 6.09

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

AbbVie's adjusted revenue per share data for the three months ended in Mar. 2024 was €6.388. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €24.39 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AbbVie Cyclically Adjusted PS Ratio Historical Data

The historical data trend for AbbVie's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Cyclically Adjusted PS Ratio Chart

AbbVie Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 6.12 6.55 6.79 5.93

AbbVie Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.49 5.34 5.77 5.93 6.88

Competitive Comparison of AbbVie's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, AbbVie's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AbbVie's Cyclically Adjusted PS Ratio falls into.



AbbVie Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

AbbVie's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=148.62/24.39
=6.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, AbbVie's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.388/129.4194*129.4194
=6.388

Current CPI (Mar. 2024) = 129.4194.

AbbVie Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.255 100.560 2.902
201409 2.419 100.428 3.117
201412 2.741 99.070 3.581
201503 2.896 99.621 3.762
201506 2.987 100.684 3.839
201509 3.183 100.392 4.103
201512 3.576 99.792 4.638
201603 3.292 100.470 4.241
201606 3.519 101.688 4.479
201609 3.494 101.861 4.439
201612 3.965 101.863 5.038
201703 3.813 102.862 4.797
201706 3.863 103.349 4.837
201709 3.661 104.136 4.550
201712 4.072 104.011 5.067
201803 4.032 105.290 4.956
201806 4.508 106.317 5.488
201809 4.659 106.507 5.661
201812 4.863 105.998 5.938
201903 4.671 107.251 5.637
201906 4.923 108.070 5.896
201909 5.191 108.329 6.202
201912 5.268 108.420 6.288
202003 5.256 108.902 6.246
202006 5.621 108.767 6.688
202009 6.175 109.815 7.277
202012 6.396 109.897 7.532
202103 6.157 111.754 7.130
202106 6.524 114.631 7.366
202109 6.860 115.734 7.671
202112 7.401 117.630 8.143
202203 6.914 121.301 7.377
202206 7.768 125.017 8.042
202209 8.423 125.227 8.705
202212 8.015 125.222 8.284
202303 6.429 127.348 6.534
202306 7.226 128.729 7.265
202309 7.368 129.860 7.343
202312 7.384 129.419 7.384
202403 6.388 129.419 6.388

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AbbVie  (WBO:ABBV) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


AbbVie Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of AbbVie's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AbbVie (WBO:ABBV) Business Description

Industry
Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

AbbVie (WBO:ABBV) Headlines